1|Page
Introduction to Clinical Pharmacology Test Bank 10th
Edition Newest Exam Preparation With Complete
Questions And Correct Answers With Rationales
Already Graded A+Brand New Version!!
1. A patient with cirrhosis is prescribed a medication with high first-pass
metabolism. The nurse anticipates that the patient will require what
dosage adjustment?
A. A higher dose because liver function is diminished
B. A lower dose because hepatic extraction is reduced
C. The same dose because first-pass metabolism occurs in the intestine
D. A higher dose because protein binding is increased
Answer: B
Explanation: In cirrhosis, portal-systemic shunting and reduced
hepatocyte function decrease first-pass extraction. More of the drug
reaches systemic circulation unchanged, so a lower dose is required to
avoid toxicity.
2. The therapeutic index of a drug is defined as the ratio of:
,2|Page
A. The effective dose to the lethal dose in 50% of the population
B. The toxic dose to the therapeutic dose
C. The maximum concentration to the minimum concentration
D. The volume of distribution to the clearance rate
Answer: B
Explanation: The therapeutic index (TI) is TD50/ED50, or the ratio of the
toxic dose to the therapeutic dose. A narrow TI indicates a drug with a
small margin of safety, requiring careful monitoring.
3. A medication that is a weak acid, such as aspirin, is primarily
absorbed in the stomach because:
A. The acidic environment favors the ionized form, which is lipid-soluble
B. The acidic environment favors the non-ionized form, which is lipid-
soluble
C. The alkaline environment favors the non-ionized form, which is
water-soluble
D. The stomach has a large surface area for absorption
Answer: B
Explanation: Weak acids are largely non-ionized in acidic environments.
The non-ionized form is more lipid-soluble and crosses cell membranes
readily, promoting absorption in the stomach. The intestine has larger
surface area but is more alkaline.
,3|Page
4. A drug administered intravenously has a bioavailability of:
A. Less than 100% due to first-pass metabolism
B. Exactly 100% because it bypasses absorption barriers
C. Between 50% and 80% depending on protein binding
D. Variable based on the rate of infusion
Answer: B
Explanation: Bioavailability is the fraction of an administered dose that
reaches systemic circulation unchanged. Intravenous administration
bypasses all barriers to absorption, so bioavailability is defined as 100%.
5. The volume of distribution (Vd) of a drug is 50 L in a 70 kg patient.
This suggests that the drug:
A. Is confined to the plasma compartment
B. Is extensively bound to plasma proteins
C. Has extensively distributed into tissues beyond the extracellular fluid
D. Is rapidly cleared by the kidneys
Answer: C
Explanation: Total body water is ~42 L. A Vd of 50 L exceeds total body
water, indicating that the drug is sequestered in tissues, often due to
lipophilicity or binding to tissue proteins.
, 4|Page
6. A patient's renal function declines with age. The nurse understands
that this primarily affects drug elimination by:
A. Reducing glomerular filtration and active tubular secretion
B. Increasing tubular reabsorption of water-soluble drugs
C. Slowing hepatic metabolism of prodrugs
D. Increasing the volume of distribution for lipophilic drugs
Answer: A
Explanation: Age-related nephron loss reduces GFR and renal blood
flow, decreasing both filtration and secretion. This prolongs the half-life
of renally excreted drugs, necessitating dose adjustments.
7. Which statement correctly describes the process of drug excretion in
the kidney?
A. Only unbound, free drug is filtered at the glomerulus
B. Protein-bound drug is readily filtered and excreted
C. Active secretion occurs only in the proximal tubule for acidic drugs
D. Reabsorption always increases the excretion rate
Answer: A
Explanation: Glomerular filtration allows only free (unbound) drug
molecules that are small enough to pass through the capillary pores.
Protein-bound drugs are too large to be filtered.
Introduction to Clinical Pharmacology Test Bank 10th
Edition Newest Exam Preparation With Complete
Questions And Correct Answers With Rationales
Already Graded A+Brand New Version!!
1. A patient with cirrhosis is prescribed a medication with high first-pass
metabolism. The nurse anticipates that the patient will require what
dosage adjustment?
A. A higher dose because liver function is diminished
B. A lower dose because hepatic extraction is reduced
C. The same dose because first-pass metabolism occurs in the intestine
D. A higher dose because protein binding is increased
Answer: B
Explanation: In cirrhosis, portal-systemic shunting and reduced
hepatocyte function decrease first-pass extraction. More of the drug
reaches systemic circulation unchanged, so a lower dose is required to
avoid toxicity.
2. The therapeutic index of a drug is defined as the ratio of:
,2|Page
A. The effective dose to the lethal dose in 50% of the population
B. The toxic dose to the therapeutic dose
C. The maximum concentration to the minimum concentration
D. The volume of distribution to the clearance rate
Answer: B
Explanation: The therapeutic index (TI) is TD50/ED50, or the ratio of the
toxic dose to the therapeutic dose. A narrow TI indicates a drug with a
small margin of safety, requiring careful monitoring.
3. A medication that is a weak acid, such as aspirin, is primarily
absorbed in the stomach because:
A. The acidic environment favors the ionized form, which is lipid-soluble
B. The acidic environment favors the non-ionized form, which is lipid-
soluble
C. The alkaline environment favors the non-ionized form, which is
water-soluble
D. The stomach has a large surface area for absorption
Answer: B
Explanation: Weak acids are largely non-ionized in acidic environments.
The non-ionized form is more lipid-soluble and crosses cell membranes
readily, promoting absorption in the stomach. The intestine has larger
surface area but is more alkaline.
,3|Page
4. A drug administered intravenously has a bioavailability of:
A. Less than 100% due to first-pass metabolism
B. Exactly 100% because it bypasses absorption barriers
C. Between 50% and 80% depending on protein binding
D. Variable based on the rate of infusion
Answer: B
Explanation: Bioavailability is the fraction of an administered dose that
reaches systemic circulation unchanged. Intravenous administration
bypasses all barriers to absorption, so bioavailability is defined as 100%.
5. The volume of distribution (Vd) of a drug is 50 L in a 70 kg patient.
This suggests that the drug:
A. Is confined to the plasma compartment
B. Is extensively bound to plasma proteins
C. Has extensively distributed into tissues beyond the extracellular fluid
D. Is rapidly cleared by the kidneys
Answer: C
Explanation: Total body water is ~42 L. A Vd of 50 L exceeds total body
water, indicating that the drug is sequestered in tissues, often due to
lipophilicity or binding to tissue proteins.
, 4|Page
6. A patient's renal function declines with age. The nurse understands
that this primarily affects drug elimination by:
A. Reducing glomerular filtration and active tubular secretion
B. Increasing tubular reabsorption of water-soluble drugs
C. Slowing hepatic metabolism of prodrugs
D. Increasing the volume of distribution for lipophilic drugs
Answer: A
Explanation: Age-related nephron loss reduces GFR and renal blood
flow, decreasing both filtration and secretion. This prolongs the half-life
of renally excreted drugs, necessitating dose adjustments.
7. Which statement correctly describes the process of drug excretion in
the kidney?
A. Only unbound, free drug is filtered at the glomerulus
B. Protein-bound drug is readily filtered and excreted
C. Active secretion occurs only in the proximal tubule for acidic drugs
D. Reabsorption always increases the excretion rate
Answer: A
Explanation: Glomerular filtration allows only free (unbound) drug
molecules that are small enough to pass through the capillary pores.
Protein-bound drugs are too large to be filtered.
